[ET Net News Agency, 23 March 2022] SINO BIOPHARM (01177) rose 5.05% to HK$4.99.
It hits an intra-day high of HK$5, and an intra-day low of HK$4.72. The total shares
traded was 30.24 million, with a value of HK$147.99m. The active buy/sell ratio is 71:29,
with net buying turnover of HK$60.54m. UBS SEC accounts for greatest net responsive buying
turnover of HK$5.08m, with volume weighted average price of HK$4.899. CLSA LTD accounts
for greatest net responsive selling turnover of HK$10.55m, with volume weighted average
price of HK$4.879. The stock has risen a combined 8.48% over the past 3 consecutive
trading days.
The Hang Seng Index now rose 501 points, or 2.29% to 22,390; the Hang Seng China
Enterprises Index now rose 205 points, or 2.73% to 7,743; the Hang Seng TECH Index now
rose 211 points, or 4.55% to 4,865; with an overall turnover of HK$78.47b.
The SSE Composite Index now rose 15 points, or 0.46% to 3,274, with an overall turnover
of RMB212.45b.
The SZSE Component Index now rose 111 points, or 0.91% to 12,430, with an overall
turnover of RMB109.83b.

Basic Information
=================

----------------------------------
Nominal 4.990 % Chg +5.05%
High 5.000 Low 4.720
Shares Tr 30.24m Turnover 147.99m
10-D SMA 4.444 %H.V 74.753
20-D SMA 4.605 VWAP 4.893
50-D SMA 5.266 RSI14 54.936
----------------------------------
Status: Active buy/sell ratio is 71:29, with net buying turnover of HK$60.54m, rising a
combined 8.48% over the past 3 consecutive trading days

Performance of stocks in the same sector or of relevance
========================================================

Stock (Code) Price (HK$) Change (%)
----------------------------------------------
SINO BIOPHARM (01177) 4.99 +5.05
SIHUAN PHARM (00460) 1.74 +4.19
TRAD CHI MED (00570) 4.10 +4.86
CSPC PHARMA (01093) 9.06 +4.02
SIMCERE PHARMA (02096) 11.12 +9.45
FOSUN PHARMA (02196) 36.80 -3.16
WUXI APPTEC (02359) 122.00 +8.73
SH PHARMA (02607) 15.14 -2.45
PHARMARON (03759) 88.15 +7.04
ASYMCHEM (06821) 232.20 +3.66
----------------------------------------------
(ed)